001     294044
005     20250523133756.0
024 7 _ |a 10.1111/nan.13010
|2 doi
024 7 _ |a pmid:39410806
|2 pmid
024 7 _ |a 0305-1846
|2 ISSN
024 7 _ |a 1365-2990
|2 ISSN
024 7 _ |a altmetric:169421489
|2 altmetric
037 _ _ |a DKFZ-2024-02072
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chirica, Mihaela
|b 0
245 _ _ |a DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centres.
260 _ _ |a Oxford [u.a.]
|c 2024
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1729160763_16261
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a DNA methylation profiling, recently endorsed by the World Health Organisation (WHO) as a pivotal diagnostic tool for brain tumours, most commonly relies on bead arrays. Despite its widespread use, limited data exist on the technical reproducibility and potential cross-institutional differences. The LOGGIC Core BioClinical Data Bank registry conducted a prospective laboratory comparison trial with 12 international laboratories to enhance diagnostic accuracy for paediatric low-grade gliomas, focusing on technical aspects of DNA methylation data generation and profile interpretation under clinical real-time conditions.Four representative low-grade gliomas of distinct histologies were centrally selected, and DNA extraction was performed. Participating laboratories received a DNA aliquot and performed the DNA methylation-based classification and result interpretation without knowledge of tumour histology. Additionally, participants were required to interpret the copy number profile derived from DNA methylation data and conduct DNA sequencing of the BRAF hotspot p.V600 due to its relevance for low-grade gliomas. Results had to be returned within 30 days.High technical reproducibility was observed, with a median pairwise correlation of 0.99 (range 0.94-0.99) between coordinating laboratory and participants. DNA methylation-based tumour classification and copy number profile interpretation were consistent across all centres, and BRAF mutation status was accurately reported for all cases. Eleven out of 12 centres successfully reported their analysis within the 30-day timeframe.Our study demonstrates remarkable concordance in DNA methylation profiling and profile interpretation across 12 international centres. These findings underscore the potential contribution of DNA methylation analysis to the harmonisation of brain tumour diagnostics.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a CNS tumour
|2 Other
650 _ 7 |a DNA methylation
|2 Other
650 _ 7 |a interlaboratory comparison trial
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a DNA Methylation
|2 MeSH
650 _ 2 |a Child
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Glioma: genetics
|2 MeSH
650 _ 2 |a Glioma: diagnosis
|2 MeSH
650 _ 2 |a Glioma: pathology
|2 MeSH
650 _ 2 |a Brain Neoplasms: genetics
|2 MeSH
650 _ 2 |a Brain Neoplasms: diagnosis
|2 MeSH
650 _ 2 |a Brain Neoplasms: pathology
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Child, Preschool
|2 MeSH
700 1 _ |a Jurmeister, Philipp
|b 1
700 1 _ |a Teichmann, Daniel
|b 2
700 1 _ |a Koch, Arend
|b 3
700 1 _ |a Perez, Eilis
|0 P:(DE-He78)1f787894bce1fbdb7ffbef3eb118d77a
|b 4
|u dkfz
700 1 _ |a Schmid, Simone
|0 P:(DE-He78)6e4a8cc4eb35e694f95453ed8a927a83
|b 5
|u dkfz
700 1 _ |a Simon, Michèle
|b 6
700 1 _ |a Driever, Pablo Hernáiz
|b 7
700 1 _ |a Bodden, Carina
|0 P:(DE-He78)47cd5146804f8663c787b3b66fa8ffae
|b 8
|u dkfz
700 1 _ |a van Tilburg, Cornelis Martinus
|0 P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271
|b 9
|u dkfz
700 1 _ |a Hardin, Emily Cecilia
|0 P:(DE-He78)953707d4b9faf5d9183b719847bd99f0
|b 10
|u dkfz
700 1 _ |a Lavarino, Cinzia
|b 11
700 1 _ |a Hench, Jürgen
|b 12
700 1 _ |a Scheie, David
|b 13
700 1 _ |a Cryan, Jane
|b 14
700 1 _ |a Vicha, Ales
|b 15
700 1 _ |a Buttarelli, Francesca R
|b 16
700 1 _ |a Michiels, An
|b 17
700 1 _ |a Haberler, Christine
|b 18
700 1 _ |a Barahona, Paulette
|b 19
700 1 _ |a Tops, Bastiaan B J
|b 20
700 1 _ |a Jacques, Tom
|0 0000-0002-7833-2158
|b 21
700 1 _ |a Stokland, Tore
|b 22
700 1 _ |a Witt, Olaf
|0 P:(DE-He78)143af26de9d57bf624771616318aaf7c
|b 23
|u dkfz
700 1 _ |a Jones, David T W
|b 24
700 1 _ |a Capper, David
|0 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
|b 25
|u dkfz
773 _ _ |a 10.1111/nan.13010
|g Vol. 50, no. 5, p. e13010
|0 PERI:(DE-600)2008293-9
|n 5
|p e13010
|t Neuropathology & applied neurobiology
|v 50
|y 2024
|x 0305-1846
856 4 _ |u https://inrepo02.dkfz.de/record/294044/files/Neuropathology%20Appl%20Neurobio%20-%202024%20-%20Chirica%20-%20DNA%20methylation%E2%80%90array%20interlaboratory%20comparison%20trial%20demonstrates%20highly.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/294044/files/Neuropathology%20Appl%20Neurobio%20-%202024%20-%20Chirica%20-%20DNA%20methylation%E2%80%90array%20interlaboratory%20comparison%20trial%20demonstrates%20highly.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:294044
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)1f787894bce1fbdb7ffbef3eb118d77a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)6e4a8cc4eb35e694f95453ed8a927a83
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)47cd5146804f8663c787b3b66fa8ffae
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)953707d4b9faf5d9183b719847bd99f0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)143af26de9d57bf624771616318aaf7c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-02-05
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROPATH APPL NEURO : 2022
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-02-05
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-02-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-02-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-02-05
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEUROPATH APPL NEURO : 2022
|d 2024-02-05
920 1 _ |0 I:(DE-He78)BE01-20160331
|k BE01
|l DKTK Koordinierungsstelle Berlin
|x 0
920 1 _ |0 I:(DE-He78)B360-20160331
|k B360
|l Pädiatrische Gliomforschung
|x 1
920 1 _ |0 I:(DE-He78)B310-20160331
|k B310
|l KKE Pädiatrische Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)BE01-20160331
980 _ _ |a I:(DE-He78)B360-20160331
980 _ _ |a I:(DE-He78)B310-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21